Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002823552 | SCV003614228 | uncertain significance | Inborn genetic diseases | 2022-04-07 | criteria provided, single submitter | clinical testing | The c.2607C>A (p.D869E) alteration is located in exon 15 (coding exon 14) of the WDR72 gene. This alteration results from a C to A substitution at nucleotide position 2607, causing the aspartic acid (D) at amino acid position 869 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005011134 | SCV005638140 | uncertain significance | Amelogenesis imperfecta hypomaturation type 2A3 | 2024-03-25 | criteria provided, single submitter | clinical testing |